中核秦山同位素有限公司是中国同辐股份有限公司、中核核电运行管理有限公司、海盐县国有资本投资有限公司合资成立中核秦山同位素有限公司。其中，中国同辐为控股股东。

中核秦山同位素有限公司于2021年12月31日注册成立，注册地点为浙江省海盐县。经营范围：放射性同位素、专用设备、实验分析仪器设备的科研、生产、销售和技术服务，以及相关同位素后端应用的产品开发与技术服务等。

生产线：

含5条同位素生产线，包括14C、89Sr、131I核素和60Co放射源。

经营宗旨：

以放射性同位素生产为主体，立足国内稳定同位素供应，创造良好的经济和社会效益，满足“人民对美好生活的向往”。

Zhonghe Qinshan Isotope Co., Ltd. is a joint venture established by China Isotope & Radiation Corporation, CNNP Nuclear Power Operation Management Co., Ltd., and Haiyan State owned Investment Co., Ltd. Among them, China Isotope & Radiation Corporation is the controlling shareholder.

China Nuclear Qinshan Isotope Co., Ltd. was registered and established on December 31, 2021, with its registered address in Haiyan County, Zhejiang Province. Business scope: Research, production, sales, and technical services for radioactive isotopes, specialized equipment, experimental analysis instruments and equipment, as well as product development and technical services for related isotope backend applications.

Production Line:

Contains 5 isotope production lines, including 14C, 89Sr, 131I nuclides, and 60Co radioactive sources.

Business purpose:

Taking the production of radioactive isotopes as the main body, based on stable isotope supply in China, creating good economic and social benefits, and meeting the people's desire for a better life.